Rob Pieters - Concepedia

Author

Rob Pieters

Erasmus MC - Sophia Children’s Hospital

Also Known As

Anja Möricke, Katarzyna Muszynska-Roslan, R Pieters, R. C. Pieters, R. Pieters, R.C. Pieters, Rob Pieters

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC - Sophia Children’s Hospital University of Amsterdam Princess Máxima Center Universität Hamburg University Medical Center Hamburg-Eppendorf

About

Rob Pieters is an author at Erasmus MC - Sophia Children’s Hospital specializing in medicine, molecular biology, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	160
2	Health Sciences	1	1	38
3	Natural Sciences	1	1	96
4	Cell Biology	1	1	25
5	Immunology	1	1	25

Rob Pieters

Publications

940

Citations

H-Index

Page 1

	Year	Citations
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia E. Klumper, Rob Pieters, A. Veerman, Blood	1995	217
MDR 1 expression is an independent prognostic factor for response and survival in <i>de novo</i> acute myeloid leukaemia Marry M. van den Heuvel‐Eibrink, Bronno van der Holt, Peter A.W. te Boekhorst, British Journal of Haematology	1997	100
mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method MG Rots, Gerrit Jansen, CH Van Zantwijk, Leukemia Mrna Expression LevelsHematological MalignancySystems BiologyMethotrexate Resistance-related ProteinsNatural Sciences	2000	96
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia Diana Schotte, Ellen Lange-Turenhout, Dominique J. P. M. Stumpel, Haematologica	2010	93
The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia Marissa A. H. den Hoed, Saskia M.F. Pluijm, Hester A. de Groot‐Kruseman, Haematologica	2014	66
<i>IN VITRO</i> RESISTANCE TO CYTOSINE ARABINOSIDE, NOT TO DAUNORUBICIN, IS ASSOCIATED WITH THE RISK OF RELAPSE IN <i>DE NOVO</i> ACUTE MYELOID LEUKAEMIA E. Klumper, Gert J. Ossenkoppele, Rob Pieters, British Journal of Haematology	1996	55
Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia M.L. te Winkel, Robert D. van Beek, Sabine M.P.F. de Muinck Keizer‐Schrama, Haematologica	2009	39
Bone marrow magnetic resonance studies in childhood leukemia. Evaluation of osteonecrosis Rob Pieters, A. Van Ine Brenk, A. Veerman, Cancer Bone DiseaseHematological MalignancyBone ImagingMedicineChildhood Leukemia	1987	38
Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL J A P Spijkers-Hagelstein, Sandra S. Pinhanços, Pauline Schneider, Leukemia Genetic AnalysisAllelic VariantGenetic DisorderMedicineGenetics	2013	37
Protection against chemotherapy induced mucositis by TGF‐β<sub>2</sub> in childhood cancer patients: Results from a randomized cross‐over study Barbara A. E. de Koning, Bertine J. Philipsen-Geerling, Maarten Hoijer, Pediatric Blood & Cancer	2006	29

Page 1